Peter Attia· MD
ostrin also known Inobosarm was probably the most well-known SARM, but it has not been FDA approved and seems to have not hit their target end points that they wanted. although it looked effective.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
ostrin also known Inobosarm was probably the most well-known SARM, but it has not been FDA approved and seems to have not hit their target end points that they wanted. although it looked effective.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
ostarin also known as enobosarm was probably the most well-known sarm but it has not been FDA approved and seems to have not hit their target end points that they wanted although it looked effective
ostarin also known as enobosarm was probably the most well-known sarm but it has not been FDA approved and seems to have not hit their target end points that they wanted although it looked effective